New scanner aims to spot lung cancer more clearly
NCT ID NCT06440616
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new type of CT scanner (photon counting CT) that provides extra image details, like color maps of tissues. The goal is to see if these detailed images help doctors diagnose lung cancer more accurately and reduce the number of extra tests needed. About 1000 adults suspected of having lung cancer will take part, and their scans will be read either with or without the extra image information.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Photon counting CT scanner with spectral imaging
What this could lead to
If successful, this could make lung cancer diagnosis more accurate and reduce the need for follow-up scans and procedures.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The new scanner may not significantly improve outcomes or reduce costs in practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASM MALIGNANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Copenhagen University Hospital Herlev
RECRUITINGHerlev, Capital Region, 2730, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••